Evidence map›Paper›PMID 27209292›Full record

Trial reportClinical pharmacokinetics2016

Neonatal Maturation of Paracetamol (Acetaminophen) Glucuronidation, Sulfation, and Oxidation Based on a Parent-Metabolite Population Pharmacokinetic Model.

Sarah F Cook, Chris Stockmann, Samira Samiee-Zafarghandy, Amber D King, Nina Deutsch, Elaine F Williams, Diana G Wilkins, Catherine M T Sherwin, John N van den Anker

Registry-linked trialAbstract readClinical Trial
In one paragraph

Trial report in Clinical pharmacokinetics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01328808 (Metabolism and Toxicity of Acetaminophen in Preterm Infants), which is not on this map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
8.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01328808 phase2 / phase3unknown statusnot on this map

Metabolism and Toxicity of Acetaminophen in Preterm Infants

TypeinterventionalSponsorJohn van den AnkerRan2011 to 2022Enrolled31ConditionsPainArmsAcetaminophen/APAP
3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 54 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 4 countries.

Sarah F CookDepartment of Pharmacology and Toxicology, Center for Human Toxicology, University of Utah, Salt Lake City, UT, USA.
Chris StockmannDivision of Clinical Pharmacology, Department of Pediatrics, University of Utah School of Medicine, 295 Chipeta Way, Salt Lake City, UT, 84108, USA.
Samira Samiee-ZafarghandyDivision of Clinical Pharmacology, Children's National Health System, Washington, DC, USA.
Amber D KingDepartment of Pharmacology and Toxicology, Center for Human Toxicology, University of Utah, Salt Lake City, UT, USA.
Nina DeutschDivision of Anesthesiology, Sedation, and Perioperative Medicine, Children's National Health System, Washington, DC, USA.
Elaine F WilliamsDivision of Clinical Pharmacology, Children's National Health System, Washington, DC, USA.
Diana G WilkinsDepartment of Pharmacology and Toxicology, Center for Human Toxicology, University of Utah, Salt Lake City, UT, USA.
Catherine M T SherwinDivision of Clinical Pharmacology, Department of Pediatrics, University of Utah School of Medicine, 295 Chipeta Way, Salt Lake City, UT, 84108, USA. catherine.sherwin@hsc.utah.edu.
John N van den AnkerDivision of Clinical Pharmacology, Children's National Health System, Washington, DC, USA.
University of Utah · USChildren's National · USErasmus MC - Sophia Children’s Hospital · NLMcMaster University · CA

Funding

Clinical and Translational Science Institute at Children's NationalUL1TR000075 · NCATS · CHILDREN'S RESEARCH INSTITUTE · PI GUAY-WOODFORD, LISA MARIE · 2012 to 2015
$13.7M
Metabolism and Toxicity of Acetaminophen in Preterm InfantsR01HD060543 · NICHD · CHILDREN'S RESEARCH INSTITUTE · PI VAN DEN ANKER, JOHANNES NICOLAAS · 2010 to 2014
$1.5M
Postdoctoral training in Pediatric Clinical PharmacologyT32HD087969 · NICHD · CHILDREN'S RESEARCH INSTITUTE · PI VAN DEN ANKER, JOHANNES NICOLAAS · 2016 to 2020
$998k
Howard Hughes Medical InstituteNCATS NIH HHS UL1 TR000075NICHD NIH HHS R01 HD060543NICHD NIH HHS T32 HD087969
6 · The paper itself

Abstract

objectivesThis study aimed to model the population pharmacokinetics of intravenous paracetamol and its major metabolites in neonates and to identify influential patient characteristics, especially those affecting the formation clearance (CL

methodsNeonates with a clinical indication for intravenous analgesia received five 15-mg/kg doses of paracetamol at 12-h intervals (<28 weeks' gestation) or seven 15-mg/kg doses at 8-h intervals (≥28 weeks' gestation). Plasma and urine were sampled throughout the 72-h study period. Concentration-time data for paracetamol, paracetamol-glucuronide, paracetamol-sulfate, and the combined oxidative pathway metabolites (paracetamol-cysteine and paracetamol-N-acetylcysteine) were simultaneously modeled in NONMEM 7.2.

resultsThe model incorporated 259 plasma and 350 urine samples from 35 neonates with a mean gestational age of 33.6 weeks (standard deviation 6.6). CL

conclusionsThe parent-metabolite model successfully characterized the pharmacokinetics of intravenous paracetamol and its metabolites in neonates. Maturational changes in the fraction of paracetamol undergoing oxidation were small relative to between-subject variability.

Indexed as

Models, BiologicalAcetaminophenAnalgesics, Non-NarcoticCysteineDose-Response Relationship, DrugFemaleGestational AgeHumansInfant, NewbornInfant, PrematureMaleParentsProspective StudiesAcetaminophenacetaminophen cysteineacetaminophen glucuronideacetaminophen sulfate esterAnalgesics, Non-NarcoticCysteine

Identifiers

PMID27209292
PMCPMC5572771
OpenAlexW2402000540

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.